Jeanne Freddura
Corporate Officer/Principal bij COMMUNITY REDEVELOPMENT INC.
Profiel
Jeanne Freddura is currently the Senior Vice President-Finance & Development at Community Redevelopment, Inc. Her former job was as a Controller at Syntimmune, Inc. She has a graduate degree from Harvard University and an undergraduate degree from Cambridge College.
Actieve functies van Jeanne Freddura
Bedrijven | Functie | Begin |
---|---|---|
COMMUNITY REDEVELOPMENT INC. | Corporate Officer/Principal | 02-02-2022 |
Eerdere bekende functies van Jeanne Freddura
Bedrijven | Functie | Einde |
---|---|---|
Syntimmune, Inc.
Syntimmune, Inc. BiotechnologyHealth Technology Syntimmune, Inc. engages in the research and development of therapeutics for autoimmune diseases based on neonatal Fc receptor biology. Its pipeline include SYNT001 which has target indication for dermatology, hematology, and neurology. It also focuses on pre-clinical investigation of SYTN002 and related compounds such as peptide mimetics. The company was founded by Laurence J. Blumberg and Richard S. Blumberg in 2013 and is headquartered in Boston, MA. | Comptroller/Controller/Auditor | - |
Opleiding van Jeanne Freddura
Harvard University | Graduate Degree |
Cambridge College | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
COMMUNITY REDEVELOPMENT INC. | Finance |
Bedrijven in privébezit | 1 |
---|---|
Syntimmune, Inc.
Syntimmune, Inc. BiotechnologyHealth Technology Syntimmune, Inc. engages in the research and development of therapeutics for autoimmune diseases based on neonatal Fc receptor biology. Its pipeline include SYNT001 which has target indication for dermatology, hematology, and neurology. It also focuses on pre-clinical investigation of SYTN002 and related compounds such as peptide mimetics. The company was founded by Laurence J. Blumberg and Richard S. Blumberg in 2013 and is headquartered in Boston, MA. | Health Technology |